Etamivan
![]() | |
| Clinical data | |
|---|---|
| Trade names | Analepticon |
| ATC code | R07AB04 (WHO) |
| Identifiers | |
| |
| CAS Number | 304-84-7 |
| PubChem (CID) | 9363 |
| DrugBank |
DB08989 |
| ChemSpider | 8996 |
| UNII |
M44O63YPV9 |
| KEGG |
D04080 |
| ECHA InfoCard | 100.005.599 |
| Chemical and physical data | |
| Formula | C12H17NO3 |
| Molar mass | 223.268 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
Etamivan (INN, or ethamivan (USAN); trade names Analepticon and Vandid) is a respiratory stimulant drug[1] related to nikethamide. It was mainly used in the treatment of barbiturate overdose[2] and chronic obstructive pulmonary disease,[3] but has now largely fallen into disuse.
See also
References
- ↑ Hirsh K, Wang SC. Respiratory stimulant effects of ethamivan and picrotoxin. Journal of Pharmacology and Experimental Therapeutics. 1975 May;193(2):657-63.
- ↑ Wheeldon PJ, Perry AW. The use of ethamivan in the treatment of barbiturate poisoning. Canadian Medical Association Journal. 1963 Jul 6;89:20-2.
- ↑ Sproule BJ, Jans RL, Breitkreutz H, Mahon W. Effects of ethamivan in patients with chronic respiratory disease. Canadian Medical Association Journal. 1964 Dec 5;91:1203-8.
This article is issued from Wikipedia - version of the 9/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
